Tesmorelin 11MG + Ipamorelin 6MG

Tesmorelin and Ipamorelin are potent synthetic peptides designed for research applications. This combination product includes Tesmorelin at a concentration of 11mg and Ipamorelin at 6mg, offering a specialized formulation for scientists investigating growth hormone and growth hormone-releasing activity in controlled experimental settings. These peptides are commonly studied for their effects on tissue growth, regeneration, and metabolic responses.

Key Research Focus Areas

• Supports growth hormone signaling and metabolic balance
• Studied for GH release and IGF-1 pathway activity

Research Context

Tesmorelin and Ipamorelin belong to the class of growth hormone secretagogues, which stimulate the release of endogenous growth hormone (GH) from the pituitary gland. In research settings, these peptides are utilized to study mechanisms underlying GH-mediated effects on various tissues, including muscle, bone, and adipose tissue. Their distinct binding profiles and potencies make them valuable tools for dissecting specific pathways influenced by GH.

Research Overview

Tesmorelin, a modified version of GHRH (Growth Hormone-Releasing Hormone), binds selectively to GHRH receptors while demonstrating enhanced stability and prolonged activity compared to native GHRH. Ipamorelin, on the other hand, targets the ghrelin receptor with high affinity, promoting GH release in a manner independent of pituitary feedback. Together, they provide complementary approaches for modulating GH secretion and evaluating its physiological consequences.

Compliance Notice

This product is intended for use in academic and industrial research environments by qualified professionals. It must be handled in compliance with all applicable laboratory safety protocols and regulatory requirements.

For research use only. Not for human or animal consumption.